And there are lingering concerns about the possible (albeit extremely low) risk of thyroid cancer from taking Ozempic, ...

Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...

Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.

Aurinia has announced a 45% workforce reduction to bolster sales of the lupus drug Lupkynis and advance the development of ...

(RTTNews) - Johnson & Johnson (JNJ), Friday announced the submission of regulatory applications for Darzalex Faspro to the U.S. Food and Drug Administration, and Darzalex to the European Medicines ...

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

New research involving 2,000 Brits has found that people feel that their coughs and colds are getting worse and take longer ...

Hungary's Olivér Várhelyi will have to explain to Members of the European Parliament exactly how he will promote women’s ...

US healthcare giant Johnson & Johnson today revealed it has submitted applications with the US Food and drug Administration ...